Perspectives on healthcare strategy, policy, and industry from the field.
Expanding global treatment options for systemic fungal infections and neglected tropical diseases through a dual-track development strategy.
Why mAb product viability in low-income countries requires infrastructure investment — a CDMO-first model inspired by TSMC — before product development.
Striking a careful balance is the only way to deliver sustainable healthcare. An examination of OECD data and a proposal for patent-expiry-pegged universal coverage.
Incentives make society go 'round. Then why are so many employee incentivization schemes so dumb? A look at the disconnect between business objectives and HR.
Advances in healthcare research and technology are messing with traditional definitions of diseases used in practice. This is a ticking time bomb for public health.
Everybody demands it immediately, but supply is limited because we live in a real world. COVID-19 proves it.
The healthcare services market is 3x larger than tangible healthcare manufacturing sectors combined. What does this mean for how we value healthcare?
The role of asymptomatic SARS-CoV-2 transmission in driving the pandemic and why our testing strategy needs a fundamental rethink.
A look at what the post-pandemic healthcare landscape will look like and what lasting changes COVID-19 will leave behind.